- Home
- CRDL vs THCH Comparison
CRDL vs THCH Comparison
Compare CRDL & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- THCH
- Stock Information
- Founded
- CRDL 2017
- THCH 2018
- Country
- CRDL Canada
- THCH China
- Employees
- CRDL N/A
- THCH N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- THCH Blank Checks
- Sector
- CRDL Health Care
- THCH Finance
- Exchange
- CRDL Nasdaq
- THCH Nasdaq
- Market Cap
- CRDL 80.1M
- THCH 73.0M
- IPO Year
- CRDL N/A
- THCH N/A
- Fundamental
- Price
- CRDL $1.15
- THCH $2.66
- Analyst Decision
- CRDL Strong Buy
- THCH
- Analyst Count
- CRDL 3
- THCH 0
- Target Price
- CRDL $9.00
- THCH N/A
- AVG Volume (30 Days)
- CRDL 150.5K
- THCH 9.0K
- Earning Date
- CRDL 05-20-2025
- THCH 06-04-2025
- Dividend Yield
- CRDL N/A
- THCH N/A
- EPS Growth
- CRDL N/A
- THCH N/A
- EPS
- CRDL N/A
- THCH N/A
- Revenue
- CRDL N/A
- THCH $190,593,087.00
- Revenue This Year
- CRDL N/A
- THCH N/A
- Revenue Next Year
- CRDL N/A
- THCH N/A
- P/E Ratio
- CRDL N/A
- THCH N/A
- Revenue Growth
- CRDL N/A
- THCH N/A
- 52 Week Low
- CRDL $0.77
- THCH $2.15
- 52 Week High
- CRDL $3.12
- THCH $6.00
- Technical
- Relative Strength Index (RSI)
- CRDL 57.19
- THCH 45.80
- Support Level
- CRDL $1.02
- THCH $2.62
- Resistance Level
- CRDL $1.19
- THCH $2.84
- Average True Range (ATR)
- CRDL 0.07
- THCH 0.12
- MACD
- CRDL 0.01
- THCH 0.00
- Stochastic Oscillator
- CRDL 73.53
- THCH 53.33
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.